Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (3) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (1) Dhamodaran, Arunraj (1) Gerhardt, Holger Prof. Dr. (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (4) Kopp, Joachim Dr. (1) Kunz, Severine Dr. (1) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (2) Rhein, Simone Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) (-) 2017 (6) 2018 (5) (-) 2019 (6) 2020 (1) 2021 (4) 2022 (6) 2023 (4) 2024 (2) Bioinformatics and Omics Data Science (1) Biology of Malignant Lymphomas (12) Cancer Genetics and Cellular Stress Responses (1) Genetics and Genomics of Cardiovascular Diseases (2) Integrative Vascular Biology (1) (-) Molecular Immunology and Gene Therapy (15) Proteome Dynamics (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) Translational Bioinformatics (3) 15 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Molecular Immunology and Gene Therapy201520172019 Sort: Result score Newest to oldest Oldest to newest April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 15, 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann November 06, 2017 / J Exp Med Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity X. Chen L. Poncette T. Blankenstein September 15, 2017 / Canc Res CTLA4 promotes Tyk2-STAT3 dependent B-cell oncogenecity A. Herrmann C. Lahtz T. Nagao J.Y. Song W.C. Chan H. Lee C. Yue T. Look R. Muelfarth W. Li K. Jenkins J. Williams L.E. Budde S.J. Forman L.W. Kwak T. Blankenstein H. Yu May 04, 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein December 15, 2017 / Int J Cancer The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy K. Anders O. Kershaw L. Larue A.D. Gruber T. Blankenstein November 27, 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule February 01, 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem March 24, 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann Pagination Current page 1 Page 2 Next page Next › Last page Last »
April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 15, 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
November 06, 2017 / J Exp Med Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity X. Chen L. Poncette T. Blankenstein
September 15, 2017 / Canc Res CTLA4 promotes Tyk2-STAT3 dependent B-cell oncogenecity A. Herrmann C. Lahtz T. Nagao J.Y. Song W.C. Chan H. Lee C. Yue T. Look R. Muelfarth W. Li K. Jenkins J. Williams L.E. Budde S.J. Forman L.W. Kwak T. Blankenstein H. Yu
May 04, 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein
December 15, 2017 / Int J Cancer The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy K. Anders O. Kershaw L. Larue A.D. Gruber T. Blankenstein
November 27, 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule
February 01, 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem
March 24, 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann